Sangamo Therapeutics, Inc. (SGMO) has a consensus analyst rating of Hold, based on 14 analysts covering the stock. Of those, 6 recommend buying, 7 recommend holding, and 1 recommend selling.
The analyst consensus price target for SGMO is $7.25, representing a +2,734.2% upside from the current price of $0.2558. Price targets range from a low of $2.00 to a high of $19.00.
